ストックスクリーナーアプリを入手
12.95
3.14%
-0.42
アフターアワーズ：
13.69
0.74
+5.71%
Neuropace Inc (NPCE) 最新ニュース
NeuroPace Reports Strong Q1 2025 Revenue Growth - TipRanks
NeuroPace, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:NPCE) - Seeking Alpha
Earnings call transcript: NeuroPace beats Q1 2025 EPS forecast, stock rises - Investing.com Australia
NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates - Nasdaq
NeuroPace Inc SEC 10-Q Report - TradingView
Neuropace Inc reports results for the quarter ended March 31Earnings Summary - TradingView
NeuroPace Q1 2025 presentation: revenue jumps 24%, expands epilepsy treatment market - Investing.com Australia
Neuropace, Inc. Q1 Revenue USD 22.524 Million Versus. IBES Estimate USD 21.8 Million - marketscreener.com
NeuroPace Inc.: Q1 Earnings Snapshot - NewsTimes
NeuroPace Reports First Quarter 2025 Financial Results - The Manila Times
NeuroPace (NPCE) to Release Earnings on Wednesday - Defense World
Recent Price Trend in NeuroPace (NPCE) is Your Friend, Here's Why - Yahoo Finance
NeuroPace, Inc. (NASDAQ:NPCE) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable - simplywall.st
NeuroPace, Inc. (NASDAQ:NPCE) Shares Acquired by Wells Fargo & Company MN - Defense World
NeuroPace (NPCE) to Release Quarterly Earnings on Wednesday - MarketBeat
Barclays PLC Acquires 6,976 Shares of NeuroPace, Inc. (NASDAQ:NPCE) - Defense World
JPMorgan Chase & Co. Purchases 52,829 Shares of NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat
Nantahala Capital Management LLC Sells 45,817 Shares of NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat
Study: NeuroPace’s Technology Can Help Reduce Epileptic Seizures - Medical Product Outsourcing
28,547 Shares in NeuroPace, Inc. (NASDAQ:NPCE) Purchased by Walleye Capital LLC - MarketBeat
NeuroPace, Inc. (NASDAQ:NPCE) Shares Acquired by JPMorgan Chase & Co. - Defense World
Retail investors who hold 34% of NeuroPace, Inc. (NASDAQ:NPCE) gained 10%, institutions profited as well - simplywall.st
Geode Capital Management LLC Has $3.62 Million Stock Holdings in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World
Short Interest in NeuroPace, Inc. (NASDAQ:NPCE) Rises By 45.8% - MarketBeat
NeuroPace, Inc. (NASDAQ:NPCE) Sees Significant Growth in Short Interest - Defense World
NeuroPace Inc (NPCE) Trading Down 3.19% on Apr 15 - GuruFocus
NeuroPace expects minimal tariff impact, maintains guidance By Investing.com - Investing.com South Africa
NeuroPace expects minimal impact of tariffs on its operations and financial results - MSN
Neuropace Provides Update On Tariff Status - marketscreener.com
NeuroPace Reports 'Minimal impact' From Trump Tariffs - marketscreener.com
NeuroPace Expects Minimal Impact from Trade Tariffs - TipRanks
NeuroPace expects minimal tariff impact, maintains guidance - Investing.com Australia
NeuroPace Provides Update on Tariff Status - The Manila Times
US Manufacturing Shield: NeuroPace Dodges Tariff Headwinds as Peers Struggle - Stock Titan
NeuroPace stock target cut to $17 by Cantor Fitzgerald - Investing.com Australia
Contrasting DIH Holding US (NASDAQ:DHAI) & NeuroPace (NASDAQ:NPCE) - Defense World
What is Leerink Partnrs' Forecast for NeuroPace Q1 Earnings? - MarketBeat
Cantor Fitzgerald cuts NeuroPace stock target to $17 By Investing.com - Investing.com Canada
Cantor Fitzgerald cuts NeuroPace stock target to $17 - Investing.com
NeuroPace reports 82% seizure reduction in epilepsy study By Investing.com - Investing.com Australia
NeuroPace Reports Data From 3-year Post-Approval Study Of RNS System In Focal Epilepsy - Nasdaq
NeuroPace reports 82% seizure reduction in epilepsy study - Investing.com
NeuroPace announces data from long-term post-approval study of RNS System - TipRanks
0.74%
0.94%
大文字化:
|
ボリューム (24 時間):